The Human Mesenteric Lymph Node Microbiome Differentiates Between Crohn's Disease and Ulcerative Colitis.
Journal
Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676
Informations de publication
Date de publication:
01 Jan 2019
01 Jan 2019
Historique:
pubmed:
22
9
2018
medline:
15
5
2019
entrez:
22
9
2018
Statut:
ppublish
Résumé
Mesenteric lymph nodes are sites in which translocated bacteria incite and progress immunological responses. For this reason, understanding the microbiome of mesenteric lymph nodes in inflammatory bowel disease is important. The bacterial profile of Crohn's disease mesenteric lymph nodes has been analysed using culture-independent methods in only one previous study. This study aimed to investigate the mesenteric lymph node microbiota from both Crohn's disease and ulcerative colitis patients. Mesenteric lymph nodes were collected from Crohn's disease and ulcerative colitis patients undergoing resection. Total DNA was extracted from mesenteric lymph nodes and assessed for the presence of bacterial DNA [16S]. All work was completed in a sterile environment using aseptic techniques. Samples positive for 16S DNA underwent next-generation sequencing, and the identity of bacterial phyla and species were determined. Crohn's disease mesenteric lymph nodes had a distinctly different microbial profile to that observed in ulcerative colitis. The relative abundance of Firmicutes was greater in nodes from ulcerative colitis patients, whereas Proteobacteria were more abundant in Crohn's disease. Although species diversity was reduced in the mesenteric lymph nodes of patients with Crohn's disease, these lymph nodes contained greater numbers of less dominant phyla, mainly Fusobacteria. This study confirms that there are distinct differences between the Crohn's disease and ulcerative colitis mesenteric lymph node microbiomes. Such microbial differences could aid in the diagnosis of Crohn's disease or ulcerative colitis, particularly in cases of indeterminate colitis at time of resection, or help explain their mechanisms of development and progression.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
Mesenteric lymph nodes are sites in which translocated bacteria incite and progress immunological responses. For this reason, understanding the microbiome of mesenteric lymph nodes in inflammatory bowel disease is important. The bacterial profile of Crohn's disease mesenteric lymph nodes has been analysed using culture-independent methods in only one previous study. This study aimed to investigate the mesenteric lymph node microbiota from both Crohn's disease and ulcerative colitis patients.
METHODS
METHODS
Mesenteric lymph nodes were collected from Crohn's disease and ulcerative colitis patients undergoing resection. Total DNA was extracted from mesenteric lymph nodes and assessed for the presence of bacterial DNA [16S]. All work was completed in a sterile environment using aseptic techniques. Samples positive for 16S DNA underwent next-generation sequencing, and the identity of bacterial phyla and species were determined.
RESULTS
RESULTS
Crohn's disease mesenteric lymph nodes had a distinctly different microbial profile to that observed in ulcerative colitis. The relative abundance of Firmicutes was greater in nodes from ulcerative colitis patients, whereas Proteobacteria were more abundant in Crohn's disease. Although species diversity was reduced in the mesenteric lymph nodes of patients with Crohn's disease, these lymph nodes contained greater numbers of less dominant phyla, mainly Fusobacteria.
CONCLUSION
CONCLUSIONS
This study confirms that there are distinct differences between the Crohn's disease and ulcerative colitis mesenteric lymph node microbiomes. Such microbial differences could aid in the diagnosis of Crohn's disease or ulcerative colitis, particularly in cases of indeterminate colitis at time of resection, or help explain their mechanisms of development and progression.
Identifiants
pubmed: 30239655
pii: 5098279
doi: 10.1093/ecco-jcc/jjy136
pmc: PMC6302955
doi:
Substances chimiques
DNA, Bacterial
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
58-66Références
Inflamm Bowel Dis. 2001 May;7(2):136-45
pubmed: 11383587
Appl Environ Microbiol. 2001 Oct;67(10):4939-42
pubmed: 11571208
Appl Environ Microbiol. 2002 Jul;68(7):3401-7
pubmed: 12089021
Nat Rev Immunol. 2003 Apr;3(4):331-41
pubmed: 12669023
Br Med J. 1953 Jun 20;1(4824):1356-9
pubmed: 13042256
Gastroenterol Clin Biol. 1992;16(10):777-81
pubmed: 1478405
Science. 2004 Mar 12;303(5664):1662-5
pubmed: 15016999
J Clin Pathol. 2004 Dec;57(12):1233-44
pubmed: 15563659
Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2010-5
pubmed: 15684084
Science. 2005 Mar 25;307(5717):1915-20
pubmed: 15790844
Science. 2005 Jun 10;308(5728):1635-8
pubmed: 15831718
Nat Clin Pract Gastroenterol Hepatol. 2006 Jul;3(7):390-407
pubmed: 16819502
Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13780-5
pubmed: 17699621
Inflamm Bowel Dis. 2009 Aug;15(8):1183-9
pubmed: 19235886
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Bioinformatics. 2011 Mar 15;27(6):863-4
pubmed: 21278185
Gut. 2012 Jan;61(1):78-85
pubmed: 21940721
PLoS One. 2011;6(9):e25042
pubmed: 21966408
Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30
pubmed: 22001864
Nature. 2012 Jun 13;486(7402):207-14
pubmed: 22699609
Lancet. 2012 Nov 3;380(9853):1590-605
pubmed: 22914295
Nucleic Acids Res. 2013 Jan 7;41(1):e1
pubmed: 22933715
Genome Biol. 2012 Apr 16;13(9):R79
pubmed: 23013615
Nature. 2013 Feb 7;494(7435):116-20
pubmed: 23334413
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Science. 2013 Jul 5;341(6141):1237439
pubmed: 23828941
Nucleic Acids Res. 2014 Jan;42(Database issue):D633-42
pubmed: 24288368
Gut. 2014 Oct;63(10):1596-606
pubmed: 24429583
Gastroenterology. 2014 May;146(6):1489-99
pubmed: 24560869
Gut. 2015 Oct;64(10):1553-61
pubmed: 25596182
Gut. 2016 Mar;65(3):415-425
pubmed: 26045134
Front Genet. 2015 Jun 23;6:219
pubmed: 26157455
Indian J Med Res. 2015 Jul;142(1):23-32
pubmed: 26261163
Gut. 2016 Jun;65(6):954-62
pubmed: 26628508
Inflamm Bowel Dis. 2016 Apr;22(4):817-25
pubmed: 26937623
Curr Opin Gastroenterol. 2016 Jul;32(4):267-73
pubmed: 27115218
Sci Rep. 2016 Jul 14;6:29681
pubmed: 27411898
Gut. 2017 May;66(5):813-822
pubmed: 28179361
Nat Microbiol. 2017 Feb 13;2:17004
pubmed: 28191884
Microb Ecol Health Dis. 2017 May 19;28(1):1322447
pubmed: 28588430
Sci Rep. 2017 Aug 25;7(1):9523
pubmed: 28842640
World J Gastroenterol. 2017 Sep 28;23(36):6665-6673
pubmed: 29085211
J Crohns Colitis. 2018 Nov 9;12(10):1139-1150
pubmed: 29309546
Nat Microbiol. 2018 Mar;3(3):337-346
pubmed: 29311644
mSystems. 2018 Apr 24;3(3):null
pubmed: 29719871
Gut. 1978 Dec;19(12):1099-104
pubmed: 369959
Infect Immun. 1979 Jan;23(1):128-32
pubmed: 370006
Gastroenterology. 1968 Apr;54(4):575-87
pubmed: 4385122
Gastroenterology. 1970 Jan;58(1):56-61
pubmed: 4903800
Gut. 1970 Jan;11(1):1-6
pubmed: 4907839
Q J Med. 1970 Apr;39(154):265-85
pubmed: 5449592
Gut. 1969 May;10(5):334-5
pubmed: 5771664
Calif Med. 1969 Jun;110(6):455-9
pubmed: 5789139
Gastroenterology. 1967 Dec;53(6):868-73
pubmed: 6064998
Br Med Bull. 1967 Sep;23(3):285-90
pubmed: 6074280
J Clin Pathol. 1978 Jun;31(6):567-77
pubmed: 670413
Gut. 1978 Nov;19(11):1034-42
pubmed: 730070
Gastroenterology. 1994 Sep;107(3):643-9
pubmed: 8076751
Gut. 1998 Jan;42(1):29-35
pubmed: 9505882